PRECLINICAL TOXICOLOGY AND PHARMACOLOGY OF 10-ETHYL-10 DEAZA-AMINOPTERIN (10-EDAM)

被引：0
|
作者：
KINAHAN, J [1 ]
FANUCCHI, M [1 ]
VIDAL, P [1 ]
CHOU, TC [1 ]
STERNBERG, S [1 ]
FARAG, F [1 ]
NIEDZWIECKI, D [1 ]
SAMUELS, L [1 ]
SIROTNAK, F [1 ]
YOUNG, C [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [31] Preclinical pharmacology and toxicology of intravenous BPM31510, a coenzyme Q10-containing lipid nanodispersion
    Linsenmayer, David
    Kazerounian, Shiva
    Thapa, Khampaseuth
    Spencer, Carrie
    Sarma, Aishwarya
    McCook, John
    Gesta, Stephane
    Vishnudas, Vivek
    Narain, Niven R.
    Sarangarajan, Rangaprasad
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [32] PHASE-II TRIAL OF 10-DEAZA-AMINOPTERIN (DAM) IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
    CHENG, E
    CURRIE, V
    YAGODA, A
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 390 - 390
  • [33] NEW FOLATE ANALOGS OF THE 10-DEAZA-AMINOPTERIN SERIES - BASIS FOR STRUCTURAL DESIGN AND BIOCHEMICAL AND PHARMACOLOGIC PROPERTIES
    SIROTNAK, FM
    DEGRAW, JI
    MOCCIO, DM
    SAMUELS, LL
    GOUTAS, LJ
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (01) : 18 - 25
  • [34] PHASE-II STUDY OF 10-EDAM IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    GREEN, MD
    SHERMAN, P
    ZALCBERG, J
    [J]. INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 31 - 34
  • [35] Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma - Sequential phase II trials by the cancer and leukemia group B
    Kindler, HL
    Belani, CP
    Herndon, JE
    Vogelzang, NJ
    Suzuki, Y
    Green, MR
    [J]. CANCER, 1999, 86 (10) : 1985 - 1991
  • [36] PHASE-II STUDY OF CARBOPLATIN AND EDATREXATE (10-EDAM) WITH LEUCOVORIN RESCUE FOR PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    HUBER, MH
    DIMERY, IW
    BENNER, SE
    LIPPMAN, SM
    SHIRINIAN, M
    ESPARAZ, B
    FRENNING, D
    GUILLORYPEREZ, C
    HONG, WK
    [J]. INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 327 - 331
  • [37] NEW FOLATE ANALOGS OF THE 10-DEAZA-AMINOPTERIN SERIES - MARKEDLY INCREASED ANTITUMOR-ACTIVITY OF THE 10-ETHYL ANALOG COMPARED TO THE PARENT COMPOUND AND METHOTREXATE AGAINST SOME HUMAN-TUMOR XENOGRAFTS IN NUDE-MICE
    SCHMID, FA
    SIROTNAK, FM
    OTTER, GM
    DEGRAW, JI
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (05): : 551 - 553
  • [38] PRECLINICAL PHARMACOLOGY OF THE NATURAL MARINE PRODUCT DOLASTATIN-10 (NSC-376128)
    NEWMAN, RA
    FUENTES, A
    COVEY, JM
    BENVENUTO, JA
    [J]. DRUG METABOLISM AND DISPOSITION, 1994, 22 (03) : 428 - 432
  • [39] Nordic symposium on "toxicology and pharmacology without animal experiments-Will it be possible in the next 10 years?"
    Knudsen, Lisbeth E.
    Smith, Adrian
    Tornqvist, Elin
    Forsby, Anna
    Tahti, Hanna
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (05) : 560 - 567
  • [40] ANTI-TUMOR PROPERTIES OF A NEW ANALOG OF 10-DEAZA-AMINOPTERIN WITH INCREASED POTENTIAL FOR SELECTIVITY AT THE LEVEL OF MEMBRANE-TRANSPORT AND POLYGLUTAMYLATION
    SIROTNAK, FM
    DEGRAW, JI
    SCHMID, FA
    MOCCIO, DM
    SAMUELS, LL
    GOUTAS, LJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 279 - 279
12345